表紙
市場調查報告書
商品編碼
1032907

全球輸液泵市場:按配件/耗材(專用、非專用)、設備(容積式、胰島素、注射器、門診)、應用(癌症、糖尿病)、設置(醫院、家庭醫療)-2027世界預測

Global Infusion Pump Market by Accessories and Consumables (Dedicated, Non-dedicated), Devices (Volumetric, Insulin, Syringe, Ambulatory), Application (Cancer, Diabetes), & Setting (Hospital, Homecare) - Global Forecast to 2027

出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 208 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球輸液泵市場預計將從 2021 年開始以 8.8% 左右的複合年增長率增長,到 2027 年將達到約 220.6 億美元。市場的主要驅動因素是慢性病的流行、人口老齡化的加劇、對輸液泵的需求增加以及全球手術數量的增加。

此外,新興國家對特殊輸液泵的需求增加和增長潛力將提供巨大的增長機會。然而,與輸液泵相關的法規和錯誤以及回收輸液泵的增加預計將阻礙市場的增長。

本報告調查了全球輸液泵市場、市場促進和製約因素、機遇和挑戰、COVID-19 的影響、附件/耗材/設備/用途/地區的市場分析,提供了競爭條件和概況等信息的大公司。

目錄

第 1 章介紹

第二章調查方法

第 3 章執行摘要

第 4 章市場概覽

  • 簡介
  • 市場動態
    • 促進因素
    • 抑製器
    • 市場機會
    • 挑戰
  • COVID-19 對輸液泵市場的影響

第五章行業考量

  • 簡介
  • 行業趨勢

第 6 章附件/耗材:全球輸液泵市場 (2019-2027)

  • 專用配件/耗材
    • 正排量輸液泵
    • 注射器輸液泵
    • 胰島素輸液泵
    • 腸內輸液泵
    • 門診輸液泵
    • 患者管理的鎮痛輸液泵
    • 嵌入式輸液泵
  • 非專用配件/耗材
    • 輸液導管
    • IV/管理集
    • 無針接頭
    • 套管
    • 管延長組
    • 閥門
    • 其他非專用配件/耗材

第 7 章按設備分類:全球輸液泵市場 (2019-2027)

  • 按產品
    • 容量注射泵
    • 胰島素泵
    • 腸內輸液泵
    • 注射器輸液泵
    • 門診輸液泵
    • PCA 泵
    • 嵌入式輸液泵
  • 按技術
    • 常規輸液泵
    • 專用輸液泵
  • 按類型
    • 固定式輸液泵
    • 便攜式輸液泵

第 8 章按應用:全球輸液泵市場 (2019-2027)

  • 化療/腫瘤
  • 糖尿病管理
  • 消化內科
  • 疼痛管理/鎮痛
  • 兒科/新生兒科
  • 血液學
  • 其他用途

第 9 章按設置:全球輸液泵市場 (2019-2027)

  • 醫院
  • 家庭護理
  • 門診治療
  • 學術研究機構

按地區劃分的第 10 章:全球輸液泵市場 (2019-2027)

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 其他領域
    • 拉丁美洲
    • 中東和非洲

第11章競爭形勢

  • 簡介
  • 主要公司的市場份額分析(2020 年)
  • 競爭現狀和趨勢
    • 產品發佈
    • 夥伴關係、合作、合同
    • 收購
    • 擴展
    • 其他開發

第12章公司簡介

  • Becton, Dickinson and Company(美國)
  • 百特國際(美國)
  • B. Braun(德國)
  • ICU Medical(美國)
  • 費森尤斯卡比(德國)
  • Smiths Medical(美國)
  • Medtronic PLC(愛爾蘭)
  • 穆格公司(美國)
  • Avanos Medical, Inc.(美國)
  • Nipro Corporation(日本)
  • Terumo Corporation(日本)
  • Insulet Corporation(美國)
  • Ypsomed Holding AG(瑞士)
  • 串聯糖尿病護理(美國)
  • JMS Co., Ltd.(日本)
  • Micrel Medical Devices SA(希臘)
  • InfuTronix Solutions LLC(美國)
  • Zyno Medical LLC(美國)
  • 羅氏診斷(瑞士)
  • Teleflex, Inc.(美國)
  • 邁瑞醫療國際有限公司(中國)
  • Epic Medical(新加坡)
  • SOOIL Development Co., Ltd.(韓國)
  • 深圳市美瑞納生物科技有限公司(中國)
  • CODAN Medizinische Gerate GmbH & Co KG(德國)

第 13 章附錄

目錄
Product Code: MEDE2110

The global infusion pumps market is expected to grow at a CAGR of ~8.8% from 2021 to reach ~22.06 billion by 2027. The growth is primarily attributed to prevalence of chronic diseases, increasing geriatric population, rising demand for infusion pumps and increasing number of surgeries performed across the globe. However, regulatory scenario and errors associated with infusion pumps and growing trends of refurbished infusion pumps are expected to hinder the growth of this market. Rising demand of specialized infusion pumps and growth potentials in emerging countries offer significant growth opportunities.

By Accessories and Consumables: Insulin infusion pumps to register highest CAGR

Insulin infusion pumps segment is anticipated to register highest CAGR during the forecast period. The growth of this market segment can be attributed to prevalence of diabetes, ease of use owing to self-administration, low chances of error and replacement of multiple daily injections. In addition, growing development of user-friendly devices is further expected to drive the growth of this market.

By Devices: Volumetric infusion pumps dominated the infusion pump market in 2020

Based on devices, volumetric infusion pump segment accounted for the largest share of infusion pumps market in 2020. The large share of this market segment can be attributed to capability of delivering fluids, blood or total parental nutrition to patients at a predetermined rate.

By Application: Chemotherapy/Oncology segment accounted for largest share in 2020

Based on Application, Chemotherapy/Oncology segment accounted for the largest share of infusion pumps market in 2020. The large share of this segment can be ascribed by prevalence of cancer, technological advancement and availability of infusion pumps for chemotherapy.

By setting: Hospitals to dominate global infusion pump market

Based on setting, Hospitals commanded largest share of global infusion pump market in 2020. The large share of this market segment can be attributed to high purchasing power of hospitals, large patient pool and availability of trained professionals. Home care setting is expected to grow at highest CAGR during forecast period due to government initiatives to reduce healthcare costs.

By Region: Asia Pacific is expected to grow at a fastest rate

In 2020, North America accounted for the largest share of infusion pumps market. The largest share is mainly attributed to high adoption, prevalence of chronic diseases, growing geriatric population and highly developed healthcare infrastructure. However, Asia Pacific region is expected to grow at fastest CAGR during the forecast period. The growth is driven by increasing burden of cancer and diabetes in Asian countries, rising adoption of infusion pumps and increasing number of surgeries performed in these countries.

Competitive Scenario:

  • Becton Dickinson and Company (US)
  • Baxter International (US)
  • B. Braun (Germany)
  • ICU Medical (US)
  • Fresenius Kabi (Germany)
  • Smiths Medical (US)
  • Medtronic PLC (Ireland)
  • And Moog Inc. (US)
  • are the key players operating in this market.
  • Other players are
  • Avanos Medical Inc. (US)
  • Nipro Corporation (Japan)
  • Terumo Corporation (Japan)
  • Insulet Corporation (US)
  • Ypsomed Holding AG (Switzerland)
  • Tandem Diabetes Care (US)
  • JMS Co. Ltd. (Japan)
  • Micrel Medical Devices SA (Greece)
  • InfuTronix Solutions LLC (US)
  • Zyno Medical LLC (US)
  • Roche Diagnostics (Switzerland)
  • Teleflex Inc. (US)
  • Mindray Medical International Limited (China)
  • Epic Medical (Singapore)
  • SOOIL Development Co. Ltd. (South Korea)
  • Shenzhen MedRena Biotech Co. Ltd. (China)
  • And CODAN Medizinische Gerate GmbH & Co KG (Germany).

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. COVID-19 Impact of the Infusion Pumps Market

5. Industry Insights

  • 5.1. Introduction
  • 5.2. Industry Trends

6. Global Infusion Pumps Market, By Accessories and Consumables , 2019-2027 (USD Million)

  • 6.1. Dedicated Accessories and Consumables
    • 6.1.1. Volumetric infusion pumps
    • 6.1.2. Syringe infusion pumps
    • 6.1.3. Insulin infusion pumps
    • 6.1.4. Enteral infusion pumps
    • 6.1.5. Ambulatory infusion pumps
    • 6.1.6. Patient-controlled analgesia infusion pumps
    • 6.1.7. Implantable infusion pumps
  • 6.2. Non- Dedicated Accessories and Consumables
    • 6.2.1. Infusion Catheters
    • 6.2.2. IV/administration Sets
    • 6.2.3. Needleless Connectors
    • 6.2.4. Cannulas
    • 6.2.5. Tubing & Extension Sets
    • 6.2.6. Valves
    • 6.2.7. Other Non- Dedicated Accessories and Consumables

7. Global Infusion Pumps Market, By Device, 2019-2027 (USD Million)

  • 7.1. By Product
    • 7.1.1. Volumetric Infusion Pumps
    • 7.1.2. Insulin Pumps
    • 7.1.3. Enteral Infusion Pumps
    • 7.1.4. Syringe Infusion Pumps
    • 7.1.5. Ambulatory Infusion Pumps
    • 7.1.6. PCA Pumps
    • 7.1.7. Implantable Infusion Pumps
  • 7.2. By Technology
    • 7.2.1. Traditional Infusion Pumps
    • 7.2.2. Specialty Infusion Pumps
  • 7.3. By Type
    • 7.3.1. Stationary Infusion Pumps
    • 7.3.2. Portable Infusion Pumps

8. Global Infusion Pumps Market, By Application, 2019-2027 (USD Million)

  • 8.1. Chemotherapy/Oncology
  • 8.2. Diabetes Management
  • 8.3. Gastroenterology
  • 8.4. Pain Management/ Analgesia
  • 8.5. Pediatrics/Neonatology
  • 8.6. Hematology
  • 8.7. Other Applications

9. Global Infusion Pumps Market, By Setting, 2019-2027 (USD Million)

  • 9.1. Hospitals
  • 9.2. Home care settings
  • 9.3. Ambulatory Care Setting
  • 9.4. Academic and Research Institutes

10. Global Infusion Pumps Market, By Geography, 2019-2027 (USD Million)

  • 10.1. North America
    • 10.1.1. US
    • 10.1.2. Canada
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. UK
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Rest of Asia-Pacific
  • 10.4. Rest of the World
    • 10.4.1. Latin America
    • 10.4.2. Middle East & Africa

11. Competitive Landscape

  • 11.1. Introduction
  • 11.2. Market Share Analysis, By Key Players (2020)
  • 11.3. Competitive Situation and Trends
    • 11.3.1. Product Launches
    • 11.3.2. Partnerships, Collaborations and Agreements
    • 11.3.3. Acquisitions
    • 11.3.4. Expansions
    • 11.3.5. Other Developments

12. Company Profiles

  • 12.1. Becton, Dickinson and Company (US)
  • 12.2. Baxter International (US)
  • 12.3. B. Braun (Germany)
  • 12.4. ICU Medical (US)
  • 12.5. Fresenius Kabi (Germany)
  • 12.6. Smiths Medical (US)
  • 12.7. Medtronic PLC (Ireland)
  • 12.8. Moog Inc. (US)
  • 12.9. Avanos Medical, Inc. (US)
  • 12.10. Nipro Corporation (Japan)
  • 12.11. Terumo Corporation (Japan)
  • 12.12. Insulet Corporation (US)
  • 12.13. Ypsomed Holding AG (Switzerland)
  • 12.14. Tandem Diabetes Care (US)
  • 12.15. JMS Co., Ltd. (Japan)
  • 12.16. Micrel Medical Devices SA (Greece)
  • 12.17. InfuTronix Solutions LLC (US)
  • 12.18. Zyno Medical LLC (US)
  • 12.19. Roche Diagnostics (Switzerland)
  • 12.20. Teleflex, Inc. (US)
  • 12.21. Mindray Medical International Limited (China)
  • 12.22. Epic Medical (Singapore)
  • 12.23. SOOIL Development Co., Ltd. (South Korea)
  • 12.24. Shenzhen MedRena Biotech Co., Ltd. (China)
  • 12.25. CODAN Medizinische Gerate GmbH & Co KG (Germany).

13. Appendix